Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,693,495 papers from all fields of science
Search
Sign In
Create Free Account
Poloxamer 188
Known as:
Poloxamer 188 [Chemical/Ingredient]
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
36 relations
0.5 ML choriogonadotropin alfa 0.5 MG/ML Prefilled Syringe [Ovidrel]
0.75 ML Follitropin Alfa 600 UNT/ML Pen Injector [Gonal F]
1 ML abatacept 125 MG/ML Prefilled Syringe [Orencia]
1.5 ML Follitropin Alfa 600 UNT/ML Pen Injector [Gonal F]
Expand
Broader (1)
Poloxamer
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Physicochemical features and transfection properties of chitosan/poloxamer 188/poly(D,L-lactide-co-glycolide) nanoplexes
D. Cosco
,
C. Federico
,
+5 authors
M. Fresta
International Journal of Nanomedicine
2014
Corpus ID: 999919
The aim of this study was the evaluation of the effects of two emulsifiers on the physicochemical and technological properties of…
Expand
2009
2009
Effects of poloxamer 188 on phospholipid monolayer morphology: an atomic force microscopy study.
Guohui Wu
,
Ka Yee C. Lee
Langmuir
2009
Corpus ID: 36096904
P188, a triblock copolymer of the form poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO) is known as…
Expand
2006
2006
Treatment with the Non-ionic Surfactant Poloxamer P188 Reduces DNA Fragmentation in Cells from Bovine Chondral Explants Exposed to Injurious Unconfined Compression
D. Baars
,
S. Rundell
,
R. Haut
Biomechanics and Modeling in Mechanobiology
2006
Corpus ID: 25291205
Excessive mechanical loading to a joint has been linked with the development of post-traumatic osteoarthritis (OA). Among the…
Expand
Review
2004
Review
2004
Purified Poloxamer 188 for Sickle Cell Vaso-Occlusive Crisis
W. Gibbs
,
T. Hagemann
The Annals of Pharmacotherapy
2004
Corpus ID: 25302444
OBJECTIVE To review available literature on the pharmacology, pharmacokinetics, efficacy, toxicology, adverse effects, drug…
Expand
Highly Cited
2004
Highly Cited
2004
Safety of Purified Poloxamer 188 in Sickle Cell Disease: Phase I Study of a Non‐ionic Surfactant in the Management of Acute Chest Syndrome
S. Ballas
,
B. Files
,
+7 authors
Michael Grindel
Hemoglobin
2004
Corpus ID: 43170631
Acute chest syndrome (ACS) is the most common cause of death in patients with sickle cell anemia. Its management is primarily…
Expand
Highly Cited
2003
Highly Cited
2003
Polyester-Poly(Ethylene Glycol) Nanoparticles Loaded with the Pure Antiestrogen RU 58668: Physicochemical and Opsonization Properties
T. Ameller
,
V. Marsaud
,
P. Legrand
,
R. Gref
,
G. Barratt
,
J. Renoir
Pharmaceutical Research
2003
Corpus ID: 20249082
AbstractPurpose. The pure antiestrogen RU58668 (RU) was encapsulated within nanospheres (NS) and nanocapsules (NC) prepared from…
Expand
2003
2003
Lysophosphatidylcholine-induced myocardial damage is inhibited by pretreatment with poloxamer 188 in isolated rat heart
Makino Watanabe
,
T. Okada
Molecular and Cellular Biochemistry
2003
Corpus ID: 27134684
Lysophosphatidylcholine (LPC) accumulates in myocardial tissues and coronary sinus during ischemia, and plays important role in…
Expand
2000
2000
Radiolabelled biodegradable microspheres for lung imaging.
A. Delgado
,
I. Soriano
,
E. Sánchez
,
M. Oliva
,
C. Évora
European journal of pharmaceutics and…
2000
Corpus ID: 31124184
Review
1992
Review
1992
Role of perfluorochemical emulsions in the treatment of myocardial reperfusion injury.
M. Forman
,
D. Ingram
,
J. Murray
American Heart Journal
1992
Corpus ID: 6200210
Highly Cited
1991
Highly Cited
1991
Effects of Poloxamer 188 on the Assembly, Structure and Dissolution of Fibrin Clots
M. Carr
,
P. Powers
,
Marsha C. Jones
Thrombosis and Haemostasis
1991
Corpus ID: 29543184
Summary Poloxamer 188, N.F. (RheothRx®), a nonionic block copolymer composed of 2 hydrophilic polyoxyethylene chains connected by…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE